FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAlpha Tau Medical Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
DRTS
Alpha Tau Medical Ltd. Stock AnalysisComprehensive stock analysis for Alpha Tau Medical Ltd. (DRTS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisDRTS
DRTS
Alpha Tau Medical Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
DRTS
  1. Home
  2. Stocks
  3. Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd.

🇺🇸DRTS•NASDAQ

Alpha Tau Medical Ltd.

🇺🇸DRTS•NASDAQ
Market cap
$1.09B

Your view on DRTS

Mkt Cap
$1.09B
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Alpha Tau Medical Ltd.

Industry
Biotechnology
Sector
Healthcare
CEO
Uzi Sofer
Headquarters
5 Kiryat Hamada Street, Jerusalem, IL
Industry
Biotechnology
Sector
Healthcare
CEO
Uzi Sofer
Headquarters
5 Kiryat Hamada Street, Jerusalem, IL
Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States.

Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Alpha Tau Medical Ltd.. Starting points for Alpha Tau Medical Ltd.: EPS -$1.20, beta 1.29 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Alpha Tau Medical Ltd.. Trailing twelve-month EPS for Alpha Tau Medical Ltd. stands at -$1.20. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
Analysts' target$18.00average of 3 firms, last 12 months
Current price—

Buy

Targets, low to high

$18.00

Low $8.00

Middle $16.00

High $30.00

Analyst ratings

5 firms, last 12 months
  • Strong Buy0
  • Buy5
  • Hold0
  • Sell0
  • Strong Sell0
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate−$0.15−$0.15−$1.07−$0.54
Lowest estimate−$0.15−$0.15−$1.08−$0.59
Highest estimate−$0.15−$0.14−$1.05−$0.49
Number of analysts2224
A year ago−$0.14−$0.261−$0.53—
Growth vs a year ago−7.1%—−101.5%—

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$250000.00$533333.00$375000.00$10.72M
Lowest estimate$250000.00$533333.00$375000.00$10.72M
Highest estimate$250000.00$533333.00$375000.00$10.72M
Number of analysts2222
A year ago$0.00$0.00$0.00—
Growth vs a year ago————
Recent rating and target changes (15)

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Alpha Tau Medical Ltd.. Alpha Tau Medical Ltd. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold DRTS14 companies · 8 funds
Compare DRTS with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
CATXPerspective Therapeutics, Inc.HealthcareMedical - Devices$91.0M
RADXRadiopharm Theranostics LimitedHealthcareBiotechnology$812,081
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
CKDXFOpthea LimitedHealthcareOTC$601.9M
CLAZFClaritas Pharmaceuticals, Inc.HealthcareOTC$3,659
CLCSCell Source, Inc.HealthcareOTC$24.5M
CLDICalidi Biotherapeutics, Inc.HealthcareAMEX$1.6M
CLDXCelldex Therapeutics, Inc.HealthcareNASDAQ$2.2B
CLGNCollPlant Biotechnologies Ltd.HealthcareNASDAQ$8.8M
CLLSCellectis S.A.HealthcareNASDAQ$92.8M
CLNNClene Inc.HealthcareNASDAQ$50.7M
CLRBCellectar Biosciences, Inc.HealthcareNASDAQ$8.0M
CLVLFClinuvel Pharmaceuticals LimitedHealthcareOTC$424.1M
CLYMClimb Bio, Inc.HealthcareNASDAQ$539.8M
CLYYFCelyad Oncology S.A.HealthcareOTC$6.7M
ETFs holding Alpha Tau Medical Ltd.
TickerFundFund assets% of the fund
IEFAiShares Core MSCI EAFE ETF$188.8B in assets0.00%
SCZiShares MSCI EAFE Small-Cap ETF$12.6B in assets0.02%
IZRLARK Israel Innovative Technology ETF$126M in assets1.37%
EISiShares MSCI Israel ETF$808M in assets0.20%
IXUSiShares Core MSCI Total International Stock ETF$56.4B in assets0.00%
EHLSEven Herd Long Short ETF$54M in assets0.54%
ZESM.TOBMO MSCI EAFE Small-Mid Cap Index ETF$474M in assets0.02%
IDEViShares Core MSCI International Developed Markets ETF$33.4B in assets0.00%

Largest holders first, then the funds most concentrated in DRTS.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Alpha Tau Medical Ltd., and how their positions are changing. At a $1.09B market value, institutional positions materially move Alpha Tau Medical Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Alpha Tau Medical Ltd. executives and directors. Shares of Alpha Tau Medical Ltd. have traded between $2.20 and $4.69 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Alpha Tau Medical Ltd.. Coverage tracks Alpha Tau Medical Ltd. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Alpha Tau Medical Ltd.

DRTS AnalysisFair
Past
5
Growth
2
Health
3
Profit
1
Value
1